XML 86 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
May 22, 2022
shares
Nov. 22, 2021
shares
Sep. 20, 2021
USD ($)
$ / shares
shares
Apr. 18, 2021
shares
Jan. 31, 2023
USD ($)
$ / shares
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
period
$ / shares
vote
offering
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
offering
shares
Dec. 02, 2020
shares
Oct. 31, 2010
$ / shares
shares
Stockholders' Equity [Line Items]                        
Common stock, shares authorized (in shares)               1,000,000,000 1,000,000,000     1,000,000,000
Common stock, par value (in dollars per share) | $ / shares         $ 0.001     $ 0.001 $ 0.001     $ 0.001
Preferred stock, shares authorized (in shares)               50,000,000 50,000,000     50,000,000
Preferred stock, par value (in dollars per share) | $ / shares               $ 0.001 $ 0.001     $ 0.001
Preferred stock, shares issued (in share)               0 0      
Preferred stock, shares outstanding (in shares)               0 0      
Common stock, dividends declared (in usd per share) | $ / shares               $ 0        
Voting right of common stock share holders               one        
Voting right of common stock share holders, number of votes | vote               1        
Public offering (in shares)         17,500,000              
Common stock offering price (in usd per share) | $ / shares         $ 10.00              
Public offering, option to purchase additional shares, period         30 days              
Public offering, option to purchase additional shares (in shares)         2,600,000              
Commissions, percentage of gross proceeds         5.75%              
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $         $ 189,700              
Payments of offering expense | $         $ 500              
Common stock, shares issued (in shares)               267,744,000 226,505,000      
Proceeds from issuance of common stock from equity plans | $               $ 15,319 $ 11,230 $ 31,806    
Vested and exercisable options (in shares)               30,000,000        
Weighted average remaining contractual term               5 years 2 months 12 days        
Vested and expected to vest, aggregate intrinsic value | $               $ 31,600        
Vested and expected to vest, weighted average exercise price (in usd per share) | $ / shares               $ 10.81        
Vested and expected to vest, weighted average remaining contractual life               5 years 9 months 18 days        
Intrinsic value | $               $ 8,800 $ 5,000 $ 146,100    
Weighted average grant date fair value (in usd per share) | $ / shares               $ 7.32 $ 5.93 $ 18.36    
Stock-based compensation cost capitalized in inventory | $               $ 600 $ 700      
Dividend yield               0.00% 0.00% 0.00%    
Public Stock Offering                        
Stockholders' Equity [Line Items]                        
Common stock, par value (in dollars per share) | $ / shares           $ 0.001 $ 0.001          
Public offering (in shares)           6,096,112 19,430,000          
Common stock offering price (in usd per share) | $ / shares           $ 14.25 $ 4.47          
Public offering, option to purchase additional shares, period           30 days 30 days          
Public offering, option to purchase additional shares (in shares)           914,416 2,914,500          
Issuance of common stock in Private Placement, net of issuance costs (in shares)           7,000,000 22,300,000     29,400,000    
Commissions, percentage of gross proceeds           6.00% 6.00%          
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $           $ 93,900 $ 93,900     $ 187,200    
Offering costs | $           $ 300 $ 300          
Number of offerings | offering               2   2    
Price per share (in usd per share) | $ / shares                   $ 6.40    
Shelf Offering                        
Stockholders' Equity [Line Items]                        
Shares issued (in shares)         20,100,000              
Options To Purchase Common Stock                        
Stockholders' Equity [Line Items]                        
Stock price (in usd per share) | $ / shares               $ 9.81        
Weighted average grant date fair value (in usd per share) | $ / shares               $ 7.32 $ 5.93 $ 15.53    
Proceeds from stock options exercised | $               $ 6,500 $ 3,400 $ 25,400    
Total unrecognized compensation expense | $               101,900        
Time-Based and Performance-Based Options                        
Stockholders' Equity [Line Items]                        
Intrinsic value | $               $ 31,800        
Period for recognition               5 years 10 months 24 days        
Options, exercisable, number (in shares)               10,039,742        
Options expired, weighted average exercise price (in usd per share) | $ / shares               $ 9.70        
Vested and expected to vest, outstanding (in shares)               13,026,464        
Restricted Stock Units (RSUs)                        
Stockholders' Equity [Line Items]                        
Ratio of number of shares into which the share instrument may be converted               1        
Award vesting period               4 years        
Weighted average grant date fair value, granted (in usd per share) | $ / shares               $ 9.67        
Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche One, Two, Three and Four                        
Stockholders' Equity [Line Items]                        
Vesting percentage               25.00%        
Time Based Restricted Stock Units PSU                        
Stockholders' Equity [Line Items]                        
Amount eligible to vest upon achievement of goal               2        
Time Based Restricted Stock Units RSUs and Performance Units                        
Stockholders' Equity [Line Items]                        
Total fair value of shares vested related to RSUs | $               $ 39,300 $ 39,200 $ 9,200    
Weighted average grant date fair value, granted (in usd per share) | $ / shares               $ 9.65 $ 10.15 $ 35.33    
2020 Equity Incentive Plan                        
Stockholders' Equity [Line Items]                        
Additional common stock reserved for issuance (in shares) 18,000,000                      
2020 Inducement Equity Incentive Plan                        
Stockholders' Equity [Line Items]                        
Shares authorized (in shares)                     2,500,000  
Additional common stock reserved for issuance (in shares)   360,000   750,000                
Common stock remain available for issuance (in shares)               12,800,000        
Omniome Plan                        
Stockholders' Equity [Line Items]                        
Shares authorized (in shares)     2,494,128                  
Exchange ratio     0.259204639                  
2010 Plan                        
Stockholders' Equity [Line Items]                        
Common stock remain available for issuance (in shares)               29,500,000        
ESPP                        
Stockholders' Equity [Line Items]                        
Common stock, shares issued (in shares)               4,000,000        
Common stock remain available for issuance (in shares)               12,197,447        
Weighted average grant date fair value, granted (in usd per share) | $ / shares               $ 5.34 $ 4.28 $ 25.07    
Number of purchase periods | period               4        
Purchase period of ESPP               6 months        
Percentage of fair market value at which stock can be purchased               85.00%        
Percentage of outstanding common stock used to determine annual plan increase               2.00%        
Common stock purchased under plan (in shares)               1,735,058 1,878,168 1,913,968    
Proceeds from stock options exercised | $               $ 8,800 $ 7,800 $ 6,400    
Private Placement of Common Stock                        
Stockholders' Equity [Line Items]                        
Price per share (in usd per share) | $ / shares     $ 26.75                  
Common stock, shares issued (in shares)     11,214,953                  
Proceeds from issuance of common stock from equity plans | $     $ 300,000                  
Common Stock                        
Stockholders' Equity [Line Items]                        
Issuance of common stock in Private Placement, net of issuance costs (in shares)               20,125,000   11,215,000    
Common Stock | Options To Purchase Common Stock                        
Stockholders' Equity [Line Items]                        
Period for recognition               2 years 2 months 12 days